Rho-kinase/nuclear factor-Β/angiotensinogen axis in angiotensin II-induced renal injury

Hypertension Research

Volumn 34, Issue 8, 2011, Pages 976-979

  Kobori, Hiroyuki ^a   Ozawa, Yuri ^a   Acres, Omar W ^a   Miyata, Kayoko ^a   Satou, Ryousuke ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSINOGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RHO KINASE;

ANIMAL TISSUE; ARTERIOLE; ARTICLE; KIDNEY INJURY; MALE; NONHUMAN; RAT; SYSTOLIC BLOOD PRESSURE;

ACUTE KIDNEY INJURY; ANGIOTENSIN II; ANGIOTENSINOGEN; ANIMALS; MALE; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; RHO-ASSOCIATED KINASES;

EID: 79961176619     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2011.66     Document Type: Article

References (22)

1. Brasier AR, Li J. Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 1996; 27: 465-475. (Pubitemid 26086217)
2. Falcao S, Stoyanova E, Cloutier G, Maurice RL, Gutkowska J, Lavoie JL. Mice overexpressing both human angiotensinogen and human renin as a model of superimposed preeclampsia on chronic hypertension. Hypertension 2009; 54: 1401-1407.
3. Nagai Y, Yao L, Kobori H, Miyata K, Ozawa Y, Miyatake A, Yukimura T, Shokoji T, Kimura S, Kiyomoto H, Kohno M, Abe Y, Nishiyama A. Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol 2005; 16: 703-711. (Pubitemid 41725107)
4. Urushihara M, Takamatsu M, Shimizu M, Kondo S, Kinoshita Y, Suga K, Kitamura A, Matsuura S, Yoshizumi M, Tamaki T, Kawachi H, Kagami S. ERK5 activation enhances mesangial cell viability and collagen matrix accumulation in rat progressive glomerulonephritis. Am J Physiol Renal Physiol 2010; 298: F167-F176.
5. Ohashi N, Yamamoto T, Huang Y, Misaki T, Fukasawa H, Suzuki H, Togawa A, Suzuki S, Fujigaki Y, Nakagawa T, Nakamura Y, Suzuki F, Kitagawa M, Hishida A. Intrarenal RAS activity and urinary angiotensinogen excretion in anti-thymocyte serum nephritis rats. Am J Physiol Renal Physiol 2008; 295: F1512-F1518.
6. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59: 251-287. (Pubitemid 47481436)
7. Ozawa Y, Kobori H. Crucial role of Rho-nuclear factor-kappab axis in angiotensin II-induced renal injury. Am J Physiol Renal Physiol 2007; 293: F100-F109. (Pubitemid 47345008)
8. Kobori H, Prieto-Carrasquero MC, Ozawa Y, Navar LG. AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension 2004; 43: 1126-1132. (Pubitemid 38579925)
9. Kobori H, Ozawa Y, Suzaki Y, Nishiyama A. Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol 2005; 16: 2073-2080. (Pubitemid 41716438)
10. Kanda T, Wakino S, Hayashi K, Homma K, Ozawa Y, Saruta T. Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats. Kidney Int 2003; 64: 2009-2019. (Pubitemid 37449535)
11. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002; 39: 316-322. (Pubitemid 34165142)
12. Navar LG, Mitchell KD, Harrison-Bernard LM, Kobori H, Nishiyama A. Intrarenal angiotensin II levels in normal and hypertensive states. J Renin Angiotensin Aldosterone Syst 2001; 2: S176-S184.
13. Dubey RK, Jackson EK, Luscher TF. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors. J Clin Invest 1995; 96: 141-149.
14. Vaughan DE, Lazos SA, Tong K. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis. J Clin Invest 1995; 95: 995-1001.
15. Hannken T, Schroeder R, Stahl RA, Wolf G. Angiotensin II-mediated expression of p27kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals. Kidney Int 1998; 54: 1923-1933. (Pubitemid 28533620)
16. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-1148. (Pubitemid 24176909)
17. Welch WJ, Baumgartl H, Lubbers D, Wilcox CS. Renal oxygenation defects in the spontaneously hypertensive rat: role of AT1 receptors. Kidney Int 2003; 63: 202-208. (Pubitemid 35463922)
18. Berk BC, Vallega G, Muslin AJ, Gordon HM, Canessa M, Alexander RW. Spontaneously hypertensive rat vascular smooth muscle cells in culture exhibit increased growth and Na+/H+ exchange. J Clin Invest 1989; 83: 822-829. (Pubitemid 19080612)
19. Beutler KT, Masilamani S, Turban S, Nielsen J, Brooks HL, Ageloff S, Fenton RA, Packer RK, Knepper MA. Long-term regulation of ENaC expression in kidney by angiotensin II. Hypertension 2003; 41: 1143-1150. (Pubitemid 36548617)
20. Carmines PK, Navar LG. Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to Ang II. Am J Physiol 1989; 256: F1015-F1020.
21. Wang T, Giebisch G. Effects of angiotensin II on electrolyte transport in the early and late distal tubule in rat kidney. Am J Physiol 1996; 271: F143-F149.
22. Acres OW, Satou R, Navar LG, Kobori H. Contribution of a nuclear factor-{kappa}b binding site to human angiotensinogen promoter activity i. Hypertension 2011; 57: 608-613.